NCT06662539 Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities Status COMPLETED Phase PHASE2
NCT06661018 Effect Supplementation of COenzyme Q10 in Acute STEMI Underwent PPCI Status COMPLETED Phase NA
NCT06660992 A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis Status RECRUITING Phase PHASE3
NCT06660719 Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care Status RECRUITING Phase PHASE3
NCT06660498 Pomalidomide as an Immune-enhancing Agent for the Control of HIV Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06660394 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) Status RECRUITING Phase PHASE3
NCT06660173 A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06660017 Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse Status NOT_YET_RECRUITING Phase PHASE2
NCT06659640 A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Status RECRUITING Phase PHASE1/PHASE2
NCT06659562 Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease Status COMPLETED Phase PHASE1
NCT06659549 A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD Status RECRUITING Phase PHASE2
NCT06659250 A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults Status COMPLETED Phase PHASE1
NCT06657768 A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) Status RECRUITING Phase PHASE1
NCT06657703 Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects. Status RECRUITING Phase PHASE1
NCT06657079 A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing ARDS Status COMPLETED Phase PHASE1/PHASE2
NCT06655883 A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098) Status RECRUITING Phase PHASE3
NCT06655324 A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001). Status RECRUITING Phase PHASE1
NCT06655272 OM 85 to Prevent Respiratory Infections in Older At Risk Patients Status RECRUITING Phase PHASE4